Patents Court grants declarations that dosage regimens were obvious

By Daniels M, Parsons G.

Abstract

Fujifilm Kyowa Kirin Biologics Company Ltd v Abbvie Biotechnology Ltd [2017] EWHC 395 (Pat), Patents Court, England, 3 March 2017The Patents Court has for the first time granted declarations that potentially patentable subject matter—in this case, dosage regimens—was obvious at particular dates. …read more

Source:: Journal of Intellectual Property Law & Practice